TradeFlare's AI research teams analysed ANNX on 6 market nights between May 4, 2026 and July 13, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| July 13, 2026 | BUY | $5.80 | $6.48 / $4.59 | -1.1% | -4.3% | The post-earnings drift signal suggests a short-to-medium term upward trend. |
| May 8, 2026 | BUY | $5.52 | $6.65 / $4.69 | -8.4% | -10.0% | The neutral market regime and the need for a clearer technical catalyst suggest a short-to-medium term outlook. |
| May 7, 2026 | BUY | $5.70 | $6.65 / $4.85 | -2.7% | -4.2% | The bullish sentiment and fundamental outlook suggest a medium-term upward trend, with potential catalysts driving price appreciation. |
| May 6, 2026 | BUY | $5.72 | — / — | -4.4% | -4.4% | Positive clinical trial data readouts for GBS and GA programs. |
| May 5, 2026 | BUY | $5.69 | — / — | -4.9% | -5.8% | Positive clinical trial data readouts for its pipeline. |
| May 4, 2026 | BUY | $5.75 | $7.20 / $4.87 | -0.2% | -7.6% | The stock is currently in a neutral technical range, and while fundamentals and sentiment are bullish, the high risk score necessitates waiting for a clearer technical signal. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.